FDA Grants 12-Year Exclusivity to Flublok
The U.S. Food and Drug Administration(FDA) has granted exclusivity to Flublok influenza vaccine for a period of 12 years.
Shingles Vaccine Reduces Risk of Long-Term Pain in Patients
A new study shows that people who receive a shingles vaccine but still contract shingles have a lower risk of developing post-herpatic neuralgia (PHN).
Personal Melanoma Vaccines Evoke Immune Response
In a first-in-people clinical trial, personalized tailor-made melanoma vaccines given to three patients with advanced melanoma appeared to increase the number and diversity of cancer-fighting T cells responding to the tumors.
More Is Better: High-Dose Flu Vaccine Helps Protect Seniors
Influenza vaccination represents one of the most cost-effective treatment modalities available to the older adult population.
AMA Adopts More Stringent Vaccine Requirement Policy
At its annual meeting in June, the American Medical Association (AMA) adopted a new policy to seek more stringent state immunization requirements to allow exemptions only for medical reasons.
Studies Find Interventions Increase HPV Vaccine Coverage
Three recent studies have found that interventions increase the rates of human papillomavirus (HPV) vaccination among teens and young women.
Flu Vaccine May Protect Against Guillain-Barré Syndrome
A new simulation study that evaluated the relationship between Guillain-Barré syndrome (GBS) risk and influenza vaccine and illness suggests that the vaccine reduces the risk for GBS.
Pertussis Vaccine Prevents Infant Mortality
Researchers investigated the role of one or more pertussis vaccinations in preventing pertussis-related deaths and risk markers for death among infants aged younger than 42 days.
Study Outlines Barriers to and Facilitators of Flu Vaccine Decisions
According to the 2013 National HealthInterview Survey, the most recent report used by the Centers for Disease Control and Prevention (CDC), only 29.6 percent of adults ages 18 to 48 receive the flu vaccine, and that number increases to 46.5 percent for adults ages 50 to 64and 67.9 percent for adults over 68.
Education and Storytelling: An Antidote to Parental Fears About Vaccine Safety
In the debate between personal freedom and government mandates, healthcare professionals are a reliable resource for vaccine information.